Ashland introduces Natural Line for personal care which includes hyalurotech™ sodium hyaluronate biosynthesized with biotechnology Read more about Ashland introduces Natural Line for personal care which includes hyalurotech™ sodium hyaluronate biosynthesized with biotechnology
Ashland transforms oral health into daily beauty care Read more about Ashland transforms oral health into daily beauty care
Ashland board authorizes quarterly dividend Read more about Ashland board authorizes quarterly dividend
Ashland introduces sclareance™ biofunctional natural sclareolide through biotechnology to visibly limit the appearance of dandruff Read more about Ashland introduces sclareance™ biofunctional natural sclareolide through biotechnology to visibly limit the appearance of dandruff
Ashland reports financial results(1) for fourth-fiscal quarter; issues outlook for fiscal year 2023 Read more about Ashland reports financial results(1) for fourth-fiscal quarter; issues outlook for fiscal year 2023
Investor’s Business Daily names Ashland among 100 Best ESG Companies Read more about Investor’s Business Daily names Ashland among 100 Best ESG Companies
Ashland recognized with Commitment to Life Award by Natura&Co Read more about Ashland recognized with Commitment to Life Award by Natura&Co
Ashland introduces patent pending Nutrapress™ chw organic chewable base for nutraceuticals Read more about Ashland introduces patent pending Nutrapress™ chw organic chewable base for nutraceuticals
Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program Read more about Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program